Skip to main content
Terug
ALC logo

Alcon Inc.

Datakwaliteit: 100%
ALC
NYSE Healthcare Medical - Instruments & Supplies
€ 75,26
▲ € 1,02 (1,37%)
Marktkapitalisatie: 36,68B
Dagbereik
€ 73,99 € 75,50
52-Weeksbereik
€ 71,55 € 99,20
Volume
922.556
50D / 200D Gem.
€ 80,51 / € 80,90
Vorige Slotkoers
€ 74,24

Quick Summary

Koershistorie

Financiële Trends

Sectorvergelijking

vs Healthcare sector mediaan (627 peers)

Metriek Aandeel Sector Mediaan
P/E 37,4 0,3
P/B 1,7 3,0
ROE % 4,5 3,7
Net Margin % 9,4 3,8
Rev Growth 5Y % 5,8 10,0
D/E 0,2 0,2

Koersdoel Analisten

Hold
€ 91,02 +20.9%
Low: € 80,00 High: € 101,09
Forward K/W
22,40
Forward WPA
€ 3,36
WPA Groei (sch.)
+0,0%
Omzet Sch.
10,98B

Winstschattingen

Periode WPA Sch. Omzet Sch. Analisten
FY2030 € 5,56
€ 5,46 – € 5,68
 14,05B 5
FY2029 € 4,97
€ 4,87 – € 5,07
 13,14B 10
FY2028 € 4,37
€ 2,91 – € 5,43
 12,40B 12

Earnings Surprises

Last 8 quarters
Quarter Est. EPS Actual EPS Surprise
2026-02-24 € 0,79 € 0,78 -1,3%
2025-11-11 € 0,77 € 0,79 +2,6%
2025-08-19 € 0,71 € 0,76 +7,0%
2025-05-13 € 0,76 € 0,73 -3,9%
2025-02-25 € 0,70 € 0,72 +2,9%
2024-11-12 € 0,72 € 0,81 +12,5%
2024-08-20 € 0,74 € 0,74 0,0%
2024-05-13 € 0,72 € 0,78 +8,3%

Dividend History

5 yr streak

Yield

0,00%

Payout Ratio

0,17%

Growth (3Y)

17,60%

Growth (5Y)

N/A

Ex-Date Payment Date Amount Yield
May 13, 2025 May 15, 2025 € 0,33 0,36%
May 14, 2024 May 16, 2024 € 0,26 0,30%
May 10, 2023 May 12, 2023 € 0,24 0,29%
May 03, 2022 May 05, 2022 € 0,21 0,29%
May 04, 2021 May 06, 2021 € 0,10 0,15%

Belangrijkste Punten

Revenue grew 5,83% annually over 5 years — modest growth
ROE of 4,50% is below average
Debt/Equity of 0,24 — conservative balance sheet
Generating 1,73B in free cash flow
P/E of 37,43 — premium valuation
Cash machine — converts 176,33% of earnings into free cash flow

Groei

Revenue Growth (5Y)
5,83%
Revenue (1Y)4,94%
Earnings (1Y)-3,73%
FCF Growth (3Y)79,38%

Kwaliteit

Return on Equity
4,50%
ROIC3,74%
Net Margin9,42%
Op. Margin13,08%

Veiligheid

Debt / Equity
0,24
Current Ratio2,12
Interest Coverage0,00

Waardering

P/E Ratio
37,43
Forward P/E22,40
P/B Ratio1,66
EV/EBITDA29,71
Dividend Yield0,00%

All Fundamental Metrics

Growth
Revenue Growth (1Y) 4,94% Revenue Growth (3Y) 4,88%
Earnings Growth (1Y) -3,73% Earnings Growth (3Y) 0,31%
Revenue Growth (5Y) 5,83% Earnings Growth (5Y) 27,06%
Profitability
Revenue (TTM) 10,40B Net Income (TTM) 980,00M
ROE 4,50% ROA 3,11%
Gross Margin 55,24% Operating Margin 13,08%
Net Margin 9,42% Free Cash Flow (TTM) 1,73B
ROIC 3,74% FCF Growth (3Y) 79,38%
Safety
Debt / Equity 0,24 Current Ratio 2,12
Interest Coverage 0,00
Dividends
Dividend Yield 0,00% Payout Ratio 0,17%
Dividend Growth (3Y) 17,60% Dividend Growth (5Y) N/A
Consecutive Div Years 5 yrs
Valuation
P/E Ratio 37,43 Forward P/E 22,40
P/B Ratio 1,66 P/S Ratio 3,53
PEG Ratio -11,71 Forward PEG N/A
EV/EBITDA 29,71 Fwd EV/EBITDA 13,54
Forward P/S 3,34 Fwd Earnings Yield 4,46%
FCF Yield 4,71%
Market Cap 36,68B Enterprise Value 40,40B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 10,40B 9,91B 9,46B 8,72B 8,29B
Net Income 980,00M 1,02B 974,00M 335,00M 376,00M
EPS (Diluted) 1,98 2,05 1,96 0,68 0,76
Gross Profit 5,75B 5,51B 5,25B 4,75B 4,65B
Operating Income 1,36B 1,41B 1,04B 672,00M 580,00M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 31,56B 30,35B 29,61B 29,21B 28,00B
Total Liabilities 9,52B 8,79B 8,99B 9,53B 8,74B
Shareholders' Equity 22,03B 21,55B 20,62B 19,68B 19,26B
Total Debt 5,25B 5,14B 5,14B 5,07B 4,48B
Cash & Equivalents 1,53B 1,68B 1,09B 980,00M 1,58B
Current Assets 6,45B 6,31B 5,65B 5,19B 5,39B
Current Liabilities 3,05B 2,28B 2,40B 2,74B 2,47B